These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34871335)

  • 1. Severe asthma: One disease and multiple definitions.
    Bagnasco D; Paggiaro P; Latorre M; Folli C; Testino E; Bassi A; Milanese M; Heffler E; Manfredi A; Riccio AM; De Ferrari L; Blasi F; Canevari RF; Canonica GW; Passalacqua G; ;
    World Allergy Organ J; 2021 Nov; 14(11):100606. PubMed ID: 34871335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe asthma: Comparison of different classifications of severity and control.
    Alves AM; Marques de Mello L; Lima Matos AS; Cruz ÁA
    Respir Med; 2019 Sep; 156():1-7. PubMed ID: 31376674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China.
    Zhang S; Hu C; Lu R; Niu R; Hu X; Qin L; He R; Feng J
    Adv Ther; 2018 Oct; 35(10):1578-1584. PubMed ID: 30209751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The definition of chronic lung disease in patients undergoing cardiac surgery: a comparison between the Society of Thoracic Surgeons and the American Thoracic Society/European Respiratory Society Classifications.
    Henry L; Holmes SD; Lamberti J; Halpin L; Hunt S; Ad N
    J Cardiovasc Surg (Torino); 2012 Dec; 53(6):797-804. PubMed ID: 23207564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real world effectiveness of benralizumab on respiratory function and asthma control.
    Menzella F; Fontana M; Galeone C; Ghidoni G; Capobelli S; Ruggiero P; Scelfo C; Simonazzi A; Catellani C; Livrieri F; Facciolongo NC
    Multidiscip Respir Med; 2021 Jan; 16(1):785. PubMed ID: 34733505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe asthma-A population study perspective.
    Backman H; Jansson SA; Stridsman C; Eriksson B; Hedman L; Eklund BM; Sandström T; Lindberg A; Lundbäck B; Rönmark E
    Clin Exp Allergy; 2019 Jun; 49(6):819-828. PubMed ID: 30817038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
    Crimi C; Campisi R; Cacopardo G; Intravaia R; Nolasco S; Porto M; Pelaia C; Crimi N
    World Allergy Organ J; 2020 Sep; 13(9):100462. PubMed ID: 32994855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma-COPD Overlap-A Discordance Between Patient Populations Defined by Different Diagnostic Criteria.
    Barczyk A; Maskey-Warzęchowska M; Górska K; Barczyk M; Kuziemski K; Śliwiński P; Batura-Gabryel H; Mróz R; Kania A; Obojski A; Tażbirek M; Celejewska-Wójcik N; Guziejko K; Brajer-Luftmann B; Korzybski D; Damps-Kostańska I; Krenke R
    J Allergy Clin Immunol Pract; 2019; 7(7):2326-2336.e5. PubMed ID: 31034998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Canonica GW; Malvezzi L; Blasi F; Paggiaro P; Mantero M; Senna G; Heffler E;
    Respir Med; 2020 May; 166():105947. PubMed ID: 32250875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the
    Canonica GW; Blasi F; Paggiaro P; Senna G; Passalacqua G; Spanevello A; Aliberti S; Bagnasco D; Bonavia M; Bonini M; Brussino L; Bucca C; Caiaffa MF; Calabrese C; Camiciottoli G; Caminati M; Carpagnano GE; Caruso C; Centanni S; Conte ME; Corsico AG; Cosmi L; Costantino MT; Crimi N; D'Alò S; D'Amato M; Del Giacco S; Farsi A; Favero E; Foschino Barbaro MP; Guarnieri G; Guida G; Latorre M; Lo Cicero S; Lombardi C; Macchia L; Mazza F; Menzella F; Milanese M; Montagni M; Montuschi P; Nucera E; Parente R; Patella V; Pelaia G; Pini L; Puggioni F; Ricciardi L; Ricciardolo FLM; Richeldi L; Ridolo E; Rolla G; Santus P; Scichilone N; Spadaro G; Vianello A; Viviano V; Yacoub MR; Zappa MC; Heffler E;
    World Allergy Organ J; 2020 Oct; 13(10):100464. PubMed ID: 32999699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 13. SANI clinical remission definition: a useful tool in severe asthma management.
    Canonica GW; Bagnasco D; Bondi B; Varricchi G; Paoletti G; Blasi F; Paggiaro P; Braido F;
    J Asthma; 2024 Jul; ():1-8. PubMed ID: 38984764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement.
    Virchow JC; Backer V; de Blay F; Kuna P; Ljørring C; Prieto JL; Villesen HH
    Respir Med; 2015 May; 109(5):547-56. PubMed ID: 25676887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition.
    Viegi G; Pedreschi M; Pistelli F; Di Pede F; Baldacci S; Carrozzi L; Giuntini C
    Chest; 2000 May; 117(5 Suppl 2):339S-45S. PubMed ID: 10843974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
    Chipps BE; Haselkorn T; Paknis B; Ortiz B; Bleecker ER; Kianifard F; Foreman AJ; Szefler SJ; Zeiger RS;
    J Allergy Clin Immunol; 2018 May; 141(5):1590-1597.e9. PubMed ID: 28797732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
    World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India.
    Talwar D; Singh S; Marwah V; Asawale K; Bhushan B
    Lung India; 2022; 39(1):65-69. PubMed ID: 34975055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.
    Steinacher R; Parissis JT; Strohmer B; Eichinger J; Rottlaender D; Hoppe UC; Altenberger J
    Clin Res Cardiol; 2012 Aug; 101(8):637-45. PubMed ID: 22395777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, asthma, and biological therapies: What we need to know.
    Morais-Almeida M; Aguiar R; Martin B; Ansotegui IJ; Ebisawa M; Arruda LK; Caminati M; Canonica GW; Carr T; Chupp G; Corren J; Dávila I; Park HS; Hanania NA; Rosenwasser L; Sánchez-Borges M; Virchow JC; Yáñez A; Bernstein JA; Caraballo L; Chang YS; Chikhladze M; Fiocchi A; González-Diaz SN; Tanno LK; Levin M; Ortega-Martell JA; Passalacqua G; Peden DB; Rouadi PW; Sublett JL; Wong GWK; Bleecker ER
    World Allergy Organ J; 2020 May; 13(5):100126. PubMed ID: 32426090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.